Hanbing Yu - Publications

AI-driven multi-omics integration of cancer-associated fibroblasts for prognostic modeling and therapeutic target discovery in head and neck squamous cell carcinoma.

Journal: NPJ precision oncology

Published: September 11, 2025

RNA-binding protein tristetraprolin inhibits Th2 cell activation and differentiation in allergic rhinitis by promoting TRIM18 mRNA decay.

Journal: The Journal of biological chemistry

Published: August 18, 2025

Targeting LAMP2A Enhances SELENBP1 Expression and Suppresses Malignant Behaviors in HNSCC.

Journal: Molecular cancer research : MCR

Published: April 15, 2025

Distinct gut microbiota profiles in acute vs. chronic sinusitis: potential biomarkers.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: January 26, 2025

Optimization of D-amino acid oxidase and epoxide hydrolase through high-performance characterization for targeted cancer therapy in sustainable biocatalysis.

Journal: International journal of biological macromolecules

Published: January 20, 2025

CAPRIN1/TYMS/MTHFD2 axis promotes EMT process in nasopharyngeal carcinoma development.

Journal: The international journal of biochemistry & cell biology

Published: November 23, 2024

Body weight, weight change and the risk of cardiovascular disease in patients with hypertension: a primary-care cohort study.

Journal: International journal of obesity (2005)

Published: December 04, 2022

Prognosis Value of microRNA-3677-3p in Lung Adenocarcinoma and Its Regulatory Effect on Tumor Progression.

Journal: Cancer management and research

Published: July 20, 2021